⌘K
Loading ticker…
As of 2026-08-21, Surrozen, Inc. Common (SRZN) has a 3-month relative strength percentile of 27 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 59. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 8.6%, relative volume 0.53×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
SRZN is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $3M notional.
Held by 3 ETFs · $5M across latest filings · largest weight 0.01% (IWC).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $3M | — |
| VXFVanguard Extended Market ETF | 0.00% | $2M | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SRZN Jan avg: -4.58% median: -10.31% win: 25% σ: 18.44% n: 4 2022-04-13 → 2026-07-31 | SRZN Feb avg: 33.05% median: 34.41% win: 75% σ: 27.23% n: 4 2022-04-13 → 2026-07-31 | SRZN Mar avg: -2.93% median: 3.24% win: 75% σ: 25.51% n: 4 2022-04-13 → 2026-07-31 | SRZN Apr avg: -6.98% median: -5.58% win: 40% σ: 17.42% n: 5 2022-04-13 → 2026-07-31 | SRZN May avg: -8.58% median: -3.50% win: 40% σ: 12.74% n: 5 2022-04-13 → 2026-07-31 | SRZN Jun avg: 2.33% median: -0.99% win: 40% σ: 11.98% n: 5 2022-04-13 → 2026-07-31 | SRZN Jul avg: -0.72% median: -14.41% win: 40% σ: 26.91% n: 5 2022-04-13 → 2026-07-31 | SRZN Aug avg: 6.43% median: 11.32% win: 75% σ: 26.91% n: 4 2022-04-13 → 2026-07-31 (current) | SRZN Sep avg: -3.44% median: -2.48% win: 50% σ: 15.47% n: 4 2022-04-13 → 2026-07-31 | SRZN Oct avg: 3.07% median: 10.42% win: 75% σ: 16.87% n: 4 2022-04-13 → 2026-07-31 | SRZN Nov avg: -9.74% median: 4.60% win: 50% σ: 45.29% n: 4 2022-04-13 → 2026-07-31 | SRZN Dec avg: 20.37% median: 24.09% win: 75% σ: 17.44% n: 4 2022-04-13 → 2026-07-31 |